98446-54-9

Usage

Uses

Used in Pharmaceutical Research:
4-Bromo-2-chloro-5-methoxyaniline is used as a building block in organic synthesis for the development of various bioactive compounds. It plays a crucial role in the production of pharmaceuticals due to its unique structure and reactivity.
Used in Agrochemicals:
4-Bromo-2-chloro-5-methoxyaniline is also utilized as an intermediate in the synthesis of agrochemicals, contributing to the development of effective pesticides and other agricultural products.
Used in Fine Chemicals Production:
4-Bromo-2-chloro-5-methoxyaniline serves as an essential component in the production of other fine chemicals, which are used in various industries for their specific properties and applications.
Used in Textile Industry:
As a dye intermediate, 4-Bromo-2-chloro-5-methoxyaniline is employed in the textile industry for the development of dyes and pigments, enhancing the colorfastness and quality of textiles.
Used in Polymer Chemistry:
4-Bromo-2-chloro-5-methoxyaniline also acts as a precursor in polymer chemistry, aiding in the synthesis of polymers with specific properties for use in various applications.
However, it is important to handle 4-Bromo-2-chloro-5-methoxyaniline with care due to its potential to cause skin and eye irritation, and its toxicity if ingested or inhaled. Proper safety measures should be taken during its use and storage to minimize risks.

Upstream product

• 2401-24-3 2-chloro-5-methoxyaniline 
• 7206-70-4 4-amino-5-chloro-2-methoxybenzoic acid 
• 85006-21-9 2-chloro-5-methoxyaniline hydrochloride 

Relevant academic research and scientific papers

A kind of deuterium generation 3-cyano-quinoline compound, a pharmaceutically acceptable composition, preparation method and its use

Disclosed in the invention are a deuterated 3-cyano quinoline compound or pharmaceutically acceptable salts, solvates, prodrugs, stereoisomers, tautomers, polymorphic substances, metabolites etc., and a pharmaceutical composition containing such compounds, and the use of these compounds or compositions in the preparation of drugs for treating or preventing tumours, especially drugs such as protein kinase inhibitors. Compared with the prior art, the compounds of the present invention have the clear advantages of properties such as plasma drug concentration, half-life, clearance, microsomal stability, bioavailability or enzyme inhibition and the like, and thus can more effectively inhibit the activities of more than one protein kinase and/or inhibit the growth of tumuor cells.

Pd(II)-catalyzed bromo- and chlorodecarboxylation of electron-rich arenecarboxylic acids

A bromo- and chlorodecarboxylation of various aromatic carboxylic acids catalyzed by Pd(II) has been developed in this work. A series of electron-rich arenecarboxylic acids gave the corresponding decarboxylative monohalogenation products under the typical reaction conditions.

Process for the Preparation of a Biphenyl-2-Yl carbamic Acid Ester

A novel process for the preparation of the compound of formula (II): which process comprises reacting a compound of formula (VI): with a compound of formula (IV): in a suitable solvent.

Herbicidal 1-aryl-4-substituted-1,4-dihydro-5H-tetrazol-5-ones and sulfur analogs thereof

Herbicidal aryltetrazolinones and thiones of the formula STR1 in which W is oxygen or sulfur; R is alkyl, fluoroalkyl, alkenyl, haloalkenyl, cyanoalkyl, alkylthioalkyl, haloalkoxyalkyl, trifluoromethylthio or alkoxyalkyl; one of X1 and X2 is fluorine, chlorine, or bromine and the other is fluorine, chlorine, bromine, alkyl, nitro or haloalkyl; and Z is a group selected from a variety of substituents including 2-propynyloxy as disclosed and exemplified.